$VRTX VERTEX PHARMACEUTICALS INC / MA Insider Trading Week 17/2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA in week 17/2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 01 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.64 | 10,400 | 370,656 | 406,400 | |
May 01 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 17.16 | 1,300 | 22,308 | 14,800 | |
May 01 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 126.66 | 700 | 88,662 | 386,284 | 387 K to 386.3 K (-0.18 %) |
May 01 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 125.63 | 2,000 | 251,260 | 386,984 | 389 K to 387 K (-0.51 %) |
May 01 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 124.64 | 4,700 | 585,808 | 388,984 | 393.7 K to 389 K (-1.19 %) |
May 01 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 123.72 | 4,300 | 531,996 | 393,684 | 398 K to 393.7 K (-1.08 %) |
May 01 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.64 | 10,400 | 370,656 | 397,984 | 387.6 K to 398 K (+2.68 %) |
May 01 2015 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 17.16 | 1,300 | 22,308 | 387,584 | 386.3 K to 387.6 K (+0.34 %) |
May 01 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 83.36 | 859 | 71,606 | 7,734 | |
May 01 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 125.71 | 200 | 25,142 | 18,375 | 18.6 K to 18.4 K (-1.08 %) |
May 01 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 123.85 | 500 | 61,925 | 18,575 | 19.1 K to 18.6 K (-2.62 %) |
May 01 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 122.41 | 159 | 19,463 | 19,075 | 19.2 K to 19.1 K (-0.83 %) |
May 01 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 83.36 | 859 | 71,606 | 19,234 | 18.4 K to 19.2 K (+4.67 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 77.31 | 17,000 | 1,314,270 | 51,000 | |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 45.11 | 15,563 | 702,047 | 45,312 | |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 53.74 | 18,312 | 984,087 | 27,188 | |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 134.05 | 700 | 93,835 | 127,515 | 128.2 K to 127.5 K (-0.55 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 133.34 | 3,400 | 453,356 | 128,215 | 131.6 K to 128.2 K (-2.58 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 132.44 | 6,316 | 836,491 | 131,615 | 137.9 K to 131.6 K (-4.58 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 131.27 | 4,230 | 555,272 | 137,931 | 142.2 K to 137.9 K (-2.98 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 130.33 | 11,321 | 1,475,466 | 142,161 | 153.5 K to 142.2 K (-7.38 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 129.30 | 1,100 | 142,230 | 153,482 | 154.6 K to 153.5 K (-0.71 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 128.17 | 12,933 | 1,657,623 | 154,582 | 167.5 K to 154.6 K (-7.72 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 127.49 | 21,480 | 2,738,485 | 167,515 | 189 K to 167.5 K (-11.37 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 77.31 | 17,000 | 1,314,270 | 188,995 | 172 K to 189 K (+9.88 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 45.11 | 15,563 | 702,047 | 171,995 | 156.4 K to 172 K (+9.95 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 53.74 | 18,312 | 984,087 | 156,432 | 138.1 K to 156.4 K (+13.26 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Gift | G | 0.00 | 150 | 0 | 138,120 | 138.3 K to 138.1 K (-0.11 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | M | 59.55 | 20,000 | 1,191,000 | 0 | |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | M | 53.85 | 20,000 | 1,077,000 | 0 | |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Option Exercise | M | 56.99 | 28,125 | 1,602,844 | 1,875 | |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 133.63 | 2,300 | 307,349 | 0 | 2.3 K to 0 (-100.00 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 132.82 | 5,668 | 752,824 | 2,300 | 8 K to 2.3 K (-71.13 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 131.76 | 3,969 | 522,955 | 7,968 | 11.9 K to 8 K (-33.25 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 130.58 | 8,800 | 1,149,104 | 11,937 | 20.7 K to 11.9 K (-42.44 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 129.94 | 4,500 | 584,730 | 20,737 | 25.2 K to 20.7 K (-17.83 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 128.12 | 16,295 | 2,087,715 | 25,237 | 41.5 K to 25.2 K (-39.23 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Sell | S | 127.50 | 26,593 | 3,390,608 | 41,532 | 68.1 K to 41.5 K (-39.04 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Buy | M | 59.55 | 20,000 | 1,191,000 | 68,125 | 48.1 K to 68.1 K (+41.56 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Buy | M | 53.85 | 20,000 | 1,077,000 | 48,125 | 28.1 K to 48.1 K (+71.11 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Kearney Terrence C | Director | Buy | M | 56.99 | 28,125 | 1,602,844 | 28,125 | 0 to 28.1 K |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 48.74 | 1,125 | 54,833 | 5,625 | |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 134.09 | 100 | 13,409 | 18,375 | 18.5 K to 18.4 K (-0.54 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 133.06 | 100 | 13,306 | 18,475 | 18.6 K to 18.5 K (-0.54 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 131.60 | 100 | 13,160 | 18,575 | 18.7 K to 18.6 K (-0.54 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 130.57 | 200 | 26,114 | 18,675 | 18.9 K to 18.7 K (-1.06 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 127.95 | 625 | 79,969 | 18,875 | 19.5 K to 18.9 K (-3.21 %) |
Apr 29 2015 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 48.74 | 1,125 | 54,833 | 19,500 | 18.4 K to 19.5 K (+6.12 %) |